Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMC Entertainment Holdings
AMC
|
+$36.2M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$16.5M |
| 3 |
McDonald's
MCD
|
+$14.5M |
| 4 |
Sinclair Inc
SBGI
|
+$12.6M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Independence Realty Trust
IRT
|
+$8.78M |
| 2 |
AbbVie
ABBV
|
+$8.19M |
| 3 |
Visa
V
|
+$8.05M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$7.33M |
| 5 |
Keurig Dr Pepper
KDP
|
+$7.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.78% |
| 2 | Technology | 13.29% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Rambus
RMBS
$9.44B
| $252K | 0.03% |
19,230
+6,827
| +55% | +$89.7K |
|
|
ICON
502
DELISTED
Iconix Brand Group, Inc.
ICON
| $251K | 0.03% |
+3,344
| New | +$295K |
|
503
Kulicke & Soffa
KLIC
$4.37B
| $250K | 0.03% |
12,302
-2,572
| -17% | -$49.5K |
|
|
XLRN
504
DELISTED
Acceleron Pharma
XLRN
| $250K | 0.03% |
+9,419
| New | +$248K |
|
505
Sensient Technologies
SXT
$5.85B
| $248K | 0.02% |
+3,127
| New | +$246K |
|
506
LyondellBasell Industries
LYB
$21.1B
| $246K | 0.02% |
2,693
-733
| -21% | -$66.9K |
|
507
Carnival Corporation Ltd
CCL
$35.2B
| $245K | 0.02% |
+4,163
| New | +$233K |
|
508
NVIDIA
NVDA
$5.05T
| $245K | 0.02% |
+90,000
| New | +$239K |
|
509
XPO
XPO
$22.5B
| $245K | 0.02% |
+14,787
| New | +$241K |
|
|
NBIS
510
Nebius Group N.V.
NBIS
$57.3B
| $243K | 0.02% |
+11,091
| New | +$253K |
|
|
CSGS
511
DELISTED
CSG Systems International
CSGS
| $242K | 0.02% |
+6,383
| New | +$271K |
|
512
Editas Medicine
EDIT
$461M
| $242K | 0.02% |
+10,858
| New | +$225K |
|
513
InterContinental Hotels
IHG
$24B
| $242K | 0.02% |
+4,501
| New | +$233K |
|
|
ELGX
514
DELISTED
Endologix Inc
ELGX
| $241K | 0.02% |
3,334
-4,901
| -60% | -$324K |
|
|
USG
515
DELISTED
Usg
USG
| $240K | 0.02% |
+7,556
| New | +$240K |
|
516
DaVita
DVA
$11.3B
| $239K | 0.02% |
3,517
-7,361
| -68% | -$487K |
|
517
ICU Medical
ICUI
$4.57B
| $236K | 0.02% |
+1,546
| New | +$226K |
|
518
Estee Lauder
EL
$37.7B
| $235K | 0.02% |
+2,776
| New | +$229K |
|
519
Procter & Gamble
PG
$341B
| $234K | 0.02% |
+2,604
| New | +$231K |
|
|
PHH
520
DELISTED
PHH Corporation
PHH
| $233K | 0.02% |
+18,284
| New | +$248K |
|
521
Southwest Gas
SWX
$6.49B
| $232K | 0.02% |
+2,801
| New | +$228K |
|
522
General Motors
GM
$76.3B
| $230K | 0.02% |
+6,493
| New | +$237K |
|
523
Telephone and Data Systems
TDS
$3.81B
| $228K | 0.02% |
+8,601
| New | +$246K |
|
524
Vulcan Materials
VMC
$35.8B
| $228K | 0.02% |
+1,889
| New | +$231K |
|
|
AGR
525
DELISTED
Avangrid, Inc.
AGR
| $228K | 0.02% |
5,340
-3,983
| -43% | -$163K |
|
Similar funds
Steve Schonfeld's Q1 2017 Portfolio in Review
As of Q1 2017, Steve Schonfeld held 843 positions worth $998M, up 29% from $772M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $186M of net new capital in Q1 2017, opening 316 new positions and adding to 131 existing holdings. Its largest new stake was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $8.19M trimmed.
- Steve Schonfeld's largest Q1 2017 buy was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
- Steve Schonfeld added most to Athene Holding Ltd. Class A Common Shares in Q1 2017, an estimated $16.5M increase.
- Steve Schonfeld's biggest Q1 2017 reduction was AbbVie, cutting an estimated $8.19M.
- Steve Schonfeld fully exited Independence Realty Trust in Q1 2017, selling an estimated $8.78M.
- Steve Schonfeld's ten largest holdings make up 15% of its $998M portfolio in Q1 2017.
- Steve Schonfeld opened 316 new positions and closed 270 in Q1 2017.
- Steve Schonfeld's portfolio value rose 29% quarter-over-quarter to $998M.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.